age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
56.698
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 13
|
$25-$50k
| 0
| 11,830
| 8,260.5078
| 7,625.27734
| 16
|
white
| 23.796875
| 14
| 0.860962
| 0.770996
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 100
| 8.5
| 70
| 20
| 36.09375
| null | 3.099609
| 0.599976
| 1.799805
| 135
| null | 276
| 30
| 1,350
| null | 0
|
no(M2 and SIP pres)
| 0
| 484
| 0
|
55.34
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 11
|
under $11k
| 0
| 30,451
| 18,925.0469
| 17,940.8281
| 19.333328
|
white
| 18.898438
| 24
| 0.895996
| 0.825928
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 16
| 62
| 6.799805
| 119
| 30
| 36.69531
| 240
| null | null | 0.799927
| 138
| 7.429688
| 312
| 25
| 1,775
| 0
| 0
|
<2 mo. follow-up
| 0
| 49
| 1
|
63.71799
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
| null | 0
| 6,560
| 3,361.3398
| 3,398.32812
| 11
|
white
| 16.097656
| 16
| 0.903931
| 0.837891
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 111
| 12
| 73
| 30
| 39.89844
| 166
| 3.599609
| 0.799927
| 2.099609
| 148
| 7.439453
| 141
| 56
| 1,660
| null | null |
no(M2 and SIP pres)
| 2.003906
| 482
| 0
|
70.54895
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null |
under $11k
| 0
| 14,419
| 7,425.9219
| 6,971.98828
| 14.5
|
white
| 19.597656
| 27
| 0.848999
| 0.751953
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 48
| 16.898438
| 105
| 12
| 38.09375
| 59
| 3.799805
| 1.299805
| 2.199707
| 138
| 7.359375
| 183
| 71
| 5,380
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 481
| 0
|
64.82996
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 16,287
| 9,790.8906
| 9,164.05469
| 20.5
|
white
| 17.296875
| 17
| 0.887939
| 0.812988
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 8
| 63
| 3.5
| 110
| 16
| 38.59375
| 238
| 2
| null | 3.599609
| 133
| 7.389648
| 115
| 61
| 0
| null | null | null | 2.680176
| 477
| 0
|
67.797
|
male
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 0
| 99,187
| 60,955.6562
| 52,364
| 46
|
white
| 38.09375
| 58
| 0.202972
| 0.109985
| 16
| 0
| 0
|
yes
| 0.2
| 0.2
|
no dnr
| 10
| 76
| 14.798828
| 72
| 25
| 36.19531
| 356
| 3.799805
| 0.699951
| 2
| 137
| 7.089844
| 123
| 25
| 1,320
| 0
| 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
78.836
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 140,610
| 73,381.8125
| 61,557.375
| 61.666657
|
white
| 48.296875
| 81
| 0.072998
| 0.026997
| 8
| 0
| 0
|
no
| null | null |
dnr after sadm
| 14
| 61
| 15.699219
| 79
| 30
| 38.19531
| null | null | null | 0.599976
| 136
| null | 132
| 6
| 1,550
| null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
76.49597
|
male
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
| null | 0
| 3,392
| 1,745.9248
| 1,798.71973
| null |
white
| 22.5
| 30
| 0.712891
| 0.554932
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 3
| 72
| 11.699219
| 64
| 20
| 36.29688
| null | 3.599609
| 1.099854
| 0.899902
| 136
| null | 96
| 21
| 600
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 473
| 0
|
61.40198
|
male
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
>$50k
| 0
| 54,985
| 30,964.4375
| 26,108.6094
| 30
|
white
| 51.796875
| 87
| 0.003
| 0
| 16
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 104
| 10
| 60
| 12
| 36.29688
| 108.32812
| null | null | 1.299805
| 137
| 7.399414
| 97
| 40
| 1,400
| null | null |
<2 mo. follow-up
| 2.288086
| 3
| 1
|
64.51996
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
$11-$25k
| 0
| 11,983
| 7,241.2617
| 6,769.12891
| 21
|
white
| 26.597656
| 48
| 0.769897
| 0.695923
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 6
| 55
| 11
| 71
| 14
| 36.09375
| 600
| 3.699707
| 0.699951
| 6.799805
| 138
| 7.389648
| 197
| 55
| 390
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 472
| 0
|
62.155
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 32,587
| 19,519.9062
| 14,169.4453
| 43
|
white
| 35
| 60
| 0.567993
| 0.455994
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 77
| 12.099609
| 130
| 30
| 39
| 357.125
| 2.799805
| 0.599976
| 0.899902
| 136
| 7.469727
| 140
| 9
| 1,750
| null | 1
|
<2 mo. follow-up
| 1
| 5
| 1
|
65.98499
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 16,239
| 8,887.7891
| 7,716.37891
| 17.5
|
white
| 21.5
| 24
| 0.60498
| 0.286987
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 1
| 70
| null | 80
| 20
| 34.39844
| null | null | null | 1.399902
| 126
| null | 115
| 38
| 350
| null | 3
|
<2 mo. follow-up
| 3
| 43
| 1
|
64.95599
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 10
|
$11-$25k
| 0
| 6,889
| 3,987.8144
| 3,800.53906
| 8
|
white
| 17.597656
| 12
| 0.695923
| 0.406982
| 1
| 0
| 0
|
metastatic
| 0.65
| 0.25
|
no dnr
| 6
| 54
| 18.296875
| 121
| 10
| 38.79688
| 165
| 2.699707
| 0.899902
| 1.399902
| 146
| 7.489258
| 264
| 23
| 3,751
| 0
| 2
|
no(M2 and SIP pres)
| 2
| 77
| 1
|
73.77997
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 9
| 7,095
| 5,031.3672
| 4,623.54688
| 10
|
white
| 23.5
| 20
| 0.651978
| 0.346985
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 5
| 57
| 16
| 138
| 40
| 38.09375
| 182
| 2.599609
| 1.299805
| 0.899902
| 139
| 7.449219
| 250
| 24
| 1,515
| null | null | null | 2.01709
| 166
| 1
|
48.83197
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 2
| 12
|
>$50k
| 9
| 19,926
| 10,830.2578
| 12,196.3125
| 21.5
|
white
| 30.199219
| 14
| 0.373962
| 0.087997
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 12
| 55
| 10.099609
| 49
| 10
| 38.79688
| 84.4375
| 2.899902
| 1
| 6.699219
| 139
| 7.359375
| 114
| 112
| 2,395
| null | 1
|
<2 mo. follow-up
| 1
| 59
| 1
|
99.198
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 9,626
| 5,471.4766
| 5,375.6875
| 7
|
white
| 13.699219
| 24
| 0.784912
| 0.655884
| 1
| 0
| 0
|
yes
| 0.8
| 0.7
|
dnr after sadm
| 2
| 75
| 37.695313
| 66
| 22
| 36.39844
| 187.5
| 3.199707
| 0.399963
| 1.599854
| 140
| 7.369141
| 181
| 29
| 4,525
| 1
| 2
|
no(M2 and SIP pres)
| 2
| 469
| 0
|
41.46198
|
male
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 17,453
| 10,567.6562
| 7,348.61719
| 35
|
white
| 46.398438
| 99
| 0.141998
| 0.066986
| 1
| 0
| 0
|
yes
| 0.05
| 0.05
|
dnr after sadm
| 3
| 72
| 10.099609
| 65
| 20
| 35.79688
| 148.3125
| 3.399902
| 0.399963
| 1.899902
| 135
| 7.239258
| 191
| 49
| 1,560
| null | null |
<2 mo. follow-up
| 2.099609
| 3
| 1
|
68.90594
|
female
| 0
| 14
|
Lung Cancer
|
Cancer
| 3
| 12
|
$11-$25k
| 0
| 26,221
| 13,905.5938
| 13,046.2188
| 13.333328
|
white
| 38.796875
| 35
| 0.120987
| 0.004999
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
dnr after sadm
| 2
| 140
| 7.599609
| 114
| 24
| 36.59375
| 355
| null | 0.699951
| 21.5
| 136
| 7.219727
| 187
| 174
| 625
| 0
| 0
| null | 0
| 94
| 1
|
68.06799
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| null | null | 0
| 6,274
| null | null | 5
|
white
| 22.097656
| 33
| 0.827881
| 0.718994
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 4
| 42
| 15.898438
| 70
| 37
| 39.39844
| 102.84375
| 2.299805
| 1.099854
| 1.399902
| 148
| 7.449219
| 78
| 51
| 4,460
| null | null | null | 3.650391
| 466
| 0
|
72.00494
|
female
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 9
| 66,389
| 43,857.75
| 35,243.2188
| 22.75
|
white
| 33.5
| 51
| 0.547974
| 0.43396
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 26
| 107
| 14.199219
| 100
| 12
| 38.29688
| 241
| 3
| 5.799805
| 4.5
| 144
| 7.429688
| 163
| 39
| 859
| 2
| 2
|
no(M2 and SIP pres)
| 2
| 465
| 0
|
69.21796
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 9
| 75,486
| 45,836.7188
| 37,414
| 22.333328
|
white
| 29.097656
| 35
| 0.590942
| 0.481995
| 9
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 19
| 51
| 5.899414
| 116
| 10
| 38.79688
| 55
| null | null | 2.299805
| 131
| 7.25
| 253
| 29
| 765
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 463
| 0
|
59.63599
|
male
| 0
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 0
| 5,450
| 2,994.2324
| 2,717.44922
| 17
|
black
| 19
| 31
| 0.807983
| 0.688965
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 4
| 60
| 7.899414
| 80
| 20
| 36.09375
| null | 4
| 0.599976
| 0.799927
| 130
| null | 412
| 15
| null | 0
| null |
<2 mo. follow-up
| 0.494751
| 52
| 1
|
86.13794
|
female
| 0
| 18
|
Colon Cancer
|
Cancer
| 2
| null | null | 0
| 15,685
| 9,282.5547
| 8,388.80469
| 5
|
black
| 36.5
| 20
| 0.287964
| 0.045998
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.01
|
dnr after sadm
| 2
| 195
| 18.296875
| 180
| 33
| 38.09375
| 102.84375
| null | null | 1.399902
| 137
| 7.30957
| 150
| 16
| 3,275
| 0
| null |
<2 mo. follow-up
| 0.494751
| 20
| 1
|
85.00195
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 43,153
| 29,686.2969
| 24,527.2031
| 19.333328
|
white
| 29.199219
| 42
| 0.556885
| 0.44397
| 5
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 21
| 55
| 14.398438
| 80
| 42
| 38.39844
| 153.3125
| null | null | 0.799927
| 141
| 7.399414
| 115
| 14
| 1,081
| null | 1
|
no(M2 and SIP pres)
| 1
| 460
| 0
|
52.25198
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 37,267
| 24,023.6406
| 21,515.75
| 18
|
white
| 23.699219
| 41
| 0.812988
| 0.75
| 1
| 0
| 0
|
yes
| 1
| 0.5
|
dnr after sadm
| 9
| 127
| 6.699219
| 114
| 16
| 38.59375
| 91.25
| 2.099609
| 0.199982
| 0.799927
| 141
| 7.439453
| 112
| 11
| 2,780
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 173
| 1
|
74.81494
|
female
| 1
| 8
|
Coma
|
Coma
| 3
| null | null | 0
| 41,314
| 29,420.4844
| 24,548.5156
| 35
|
white
| 31.796875
| 66
| 0.342957
| 0.270996
| 3
| 1
| 1
|
no
| 0.2
| 0.2
|
dnr after sadm
| 4
| 117
| 7.699219
| 80
| 20
| 36.09375
| 366.625
| 3.299805
| null | 0.799927
| 139
| 7.40918
| 92
| 14
| 750
| null | null |
<2 mo. follow-up
| 4.53125
| 8
| 1
|
80.99896
|
male
| 1
| 7
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 9
| 10,073
| 5,477.4531
| 4,782.07812
| 13.5
|
white
| 18.699219
| 29
| 0.590942
| 0.271973
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
dnr after sadm
| 1
| 60
| 13.699219
| 130
| 12
| 39.39844
| 58
| null | 0.699951
| 2.899902
| 141
| 7.25
| 128
| 30
| 2,226
| null | null |
<2 mo. follow-up
| 2.655273
| 7
| 1
|
69.19397
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 52,004
| 33,686.25
| 31,089.0781
| 24
|
white
| 27.398438
| 36
| 0.628906
| 0.525879
| 4
| 0
| 0
|
yes
| 0.8
| 0.5
|
dnr after sadm
| 1
| 57
| 6.599609
| 100
| 25
| 36.19531
| 304
| 3.299805
| 1.799805
| 1.099854
| 142
| 7.479492
| 109
| 14
| null | 3
| null |
adl>=4 (>=5 if sur)
| 2.510742
| 200
| 1
|
73.69495
|
female
| 1
| 8
|
Lung Cancer
|
Cancer
| 2
| 12
|
under $11k
| 9
| 25,491
| 10,699.6172
| 15,917.5391
| 15.5
|
white
| 17.398438
| 22
| 0.643921
| 0.335999
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 3
| 70
| 11.398438
| 90
| 20
| 36.09375
| null | 2.199707
| 1.899902
| 0.899902
| 132
| null | 158
| 25
| null | 0
| 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
75.27399
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 26
| null | null | null | 48
|
white
| 29.699219
| 68
| 0.54895
| 0.434998
| 1
| 1
| 0
|
no
| 0.25
| 0.25
| null | null | 63
| 1.599854
| 45
| 32
| 36.09375
| 412
| 2.399902
| 1.299805
| 1.799805
| 135
| 7.40918
| 216
| 41
| 685
| null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
42.60898
|
female
| 0
| 97
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 460,909
| null | null | 33
|
white
| 30.097656
| 50
| 0.746948
| 0.666992
| 7
| 0
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 93
| 97
| 11.699219
| 80
| 25
| 36.69531
| null | 2.399902
| 0.299988
| 0.799927
| 132
| null | 528
| 13
| 2,900
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 98
| 1
|
67.37897
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 11
| null | 0
| 14,515
| 9,983.3281
| 8,710.15625
| 13.5
|
white
| 21.398438
| 43
| 0.837891
| 0.734985
| 1
| 1
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 9
| 77
| 14.298828
| 130
| 12
| 38.89844
| 354
| 2
| null | 0.799927
| 140
| 7.479492
| 154
| 22
| 3,680
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 453
| 0
|
82.034
|
female
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 3,777
| 2,087.0606
| 1,781.3291
| 3
|
white
| 20.097656
| 25
| 0.730957
| 0.458984
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 110
| 8.798828
| 110
| 14
| 37.89844
| 192.5
| 1.899902
| 0.599976
| 6.899414
| 136
| 7.429688
| 164
| 87
| 1,490
| null | null |
<2 mo. follow-up
| 2.875488
| 28
| 1
|
75.87396
|
male
| 0
| 109
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 269,854
| null | null | 43.75
|
white
| 26.898438
| 64
| 0.602905
| 0.495972
| 4
| 1
| 0
|
yes
| 0.25
| 0.2
|
no dnr
| 109
| 81
| 6.699219
| 80
| 20
| 36.89844
| null | 3.399902
| 4.699219
| 0.799927
| 136
| null | 93
| 17
| null | null | null |
SIP>=30
| 2.406738
| 218
| 1
|
75.69598
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 9
| 50,793
| 30,239.1094
| 26,322.875
| 18.75
|
white
| 27.898438
| 42
| 0.623901
| 0.520996
| 3
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 26
| 103
| 17.097656
| 64
| 22
| 38
| 434.5625
| 3.399902
| 3.5
| 4.099609
| 153
| 7.469727
| 75
| 137
| 3,040
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 450
| 0
|
89.72998
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 14
| null | 0
| 5,463
| 3,171.1406
| 2,975.10938
| 7
|
white
| 17.097656
| 23
| 0.763916
| 0.625
| 1
| 0
| 0
|
no
| 0.2
| 0
|
dnr after sadm
| 1
| 70
| 12.099609
| 60
| 20
| 36.5
| null | 3.199707
| null | 2.199707
| 131
| null | 99
| 54
| 1,675
| 1
| null |
adl>=4 (>=5 if sur)
| 1.166748
| 100
| 1
|
70.073
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 2
| 15
|
$11-$25k
| 0
| 17,889
| 11,542.8047
| 10,139.3438
| 15
|
white
| 31.5
| 21
| 0.500977
| 0.179993
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 2
| 73
| 3.699707
| 60
| 20
| 35.59375
| null | 3.299805
| null | 1.5
| 140
| null | 203
| 32
| 1,350
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 154
| 1
|
66.32196
|
female
| 1
| 21
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 6
| null | null | 0
| 40,175
| 23,565.5156
| 21,078.0938
| 14
|
white
| 22.898438
| 47
| 0.55896
| 0.362976
| 1
| 1
| 0
|
metastatic
| 0.75
| 0.1
|
dnr after sadm
| 2
| 73
| 6.5
| 80
| 25
| 36.09375
| 242.84375
| 3.599609
| 0.5
| 2.399902
| 143
| 7.539062
| 50
| 68
| 2,100
| null | null |
<2 mo. follow-up
| 4.582031
| 21
| 1
|
90.75995
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 18,985
| 12,499.0547
| 10,377.8281
| 17.5
|
white
| 29.097656
| 54
| 0.585938
| 0.475952
| 1
| 1
| 0
|
no
| 0.7
| 0.5
|
dnr before sadm
| -1
| 123
| null | 104
| 28
| 36.19531
| 200
| 2.399902
| 0.599976
| 4.099609
| 137
| 7.449219
| 166
| 76
| 1,800
| null | null |
<2 mo. follow-up
| 4.538086
| 22
| 1
|
71.13495
|
female
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
under $11k
| 41
| 15,780
| 11,261.8438
| 9,187.79688
| 11
|
white
| 21.296875
| 24
| 0.671997
| 0.576904
| 3
| 0
| 1
|
no
| 0.4
| 0.3
|
no dnr
| 4
| 77
| 13.5
| 60
| 24
| 36.09375
| 145
| null | 0.599976
| 0.699951
| 141
| 7.359375
| 144
| 14
| 1,700
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 446
| 0
|
57.92499
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 8,734
| 5,139.0586
| 4,937.85938
| 7.5
|
hispanic
| 19.199219
| 33
| 0.887939
| 0.812988
| 1
| 1
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 9
| 65
| 11.5
| 106
| 28
| 37.79688
| null | null | null | 1
| 136
| null | 130
| 14
| 1,150
| 2
| 3
|
SIP>=30
| 3
| 446
| 0
|
89.47296
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
>$50k
| 0
| 44,299
| 26,925.4062
| 22,463.3906
| 25.5
|
white
| 20.398438
| 24
| 0.642944
| 0.542969
| 12
| 0
| 1
|
yes
| 0.8
| 0.7
|
no dnr
| 13
| 83
| 16
| 80
| 20
| 36.09375
| 214.8125
| 3.899902
| 0.899902
| 0.699951
| 142
| 7.389648
| 102
| 20
| null | null | 7
|
<2 mo. follow-up
| 7
| 43
| 1
|
68.17499
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 0
| 24,260
| 16,137.75
| 12,682.9766
| 25.5
|
white
| 31.898438
| 66
| 0.576904
| 0.46698
| 1
| 0
| 1
|
yes
| 0.5
| 0.2
|
no dnr
| 11
| 77
| 6.5
| 80
| 25
| 36.29688
| 288
| 2.899902
| null | 1
| 136
| 7.469727
| 208
| 23
| null | null | 1
|
<2 mo. follow-up
| 1
| 11
| 1
|
79.80597
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 34,574
| null | null | 29.5
|
white
| 18.597656
| 42
| 0.831909
| 0.774902
| 1
| 0
| 0
|
no
| 1
| 0.9
|
dnr after sadm
| 2
| 107
| 6.899414
| 100
| 26
| 35.39844
| null | 4
| null | 1.099854
| 139
| null | 106
| 19
| 3,250
| null | 1
|
no(M2 and SIP pres)
| 1
| 443
| 0
|
63.198
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 12
| null | 0
| 34,958
| 24,062.5781
| 20,694.8281
| 23.5
|
white
| 22.199219
| 61
| 0.716919
| 0.630981
| 2
| 1
| 0
|
yes
| 0.3
| 0.5
|
dnr after sadm
| 6
| 119
| 0.199982
| 124
| 38
| 38.59375
| 121.65625
| 2.299805
| 1.199951
| 1.399902
| 151
| 7.419922
| 145
| 27
| 3,455
| 2
| 2
|
<2 mo. follow-up
| 2
| 7
| 1
|
81.21796
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 30,348
| 16,742.7344
| 15,341.9531
| 28.5
|
white
| 16
| 18
| 0.85791
| 0.80896
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr before sadm
| -1
| 62
| 14.398438
| 180
| 12
| 38
| 197.5
| null | null | 4.799805
| 140
| 7.449219
| 179
| 45
| 540
| null | 4
|
SIP>=30
| 4
| 440
| 0
|
56.556
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 11,227
| null | null | 6.5
|
white
| 19.898438
| 36
| 0.897949
| 0.827881
| 1
| 1
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 7
| 53
| 20.898438
| 120
| 8
| 32.59375
| 48
| 1
| null | 1.199951
| 130
| 7.379883
| 147
| 13
| 419
| 0
| 0
| null | 0
| 437
| 0
|
91.01996
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
$25-$50k
| 37
| 18,010
| null | null | 14
|
white
| 17.296875
| 26
| 0.703979
| 0.61499
| 1
| 0
| 0
|
no
| 0.85
| 0.614125
|
dnr after sadm
| 1
| 127
| 11.199219
| 80
| 20
| 36.09375
| null | 3.599609
| null | 3.899902
| 142
| null | 124
| 56
| null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 438
| 0
|
40.67599
|
female
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
>$50k
| 0
| 89,921
| 67,147.9375
| 53,362.0938
| 34.75
|
white
| 39.09375
| 45
| 0.633911
| 0.531982
| 1
| 0
| 0
|
no
| 0.65
| 0.65
|
no dnr
| 28
| 38
| 1
| 140
| 32
| 36.29688
| 193.3125
| null | null | 2.599609
| 146
| 7.389648
| 146
| 82
| 0
| null | 0
|
no(M2 and SIP pres)
| 0
| 437
| 0
|
81.00195
|
male
| 0
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
under $11k
| 0
| 79,981
| 45,042.25
| 37,953.8125
| 17.75
|
white
| 21.898438
| 34
| 0.780884
| 0.710938
| 1
| 0
| 0
|
no
| 0.6
| 0.55
|
dnr after sadm
| 33
| 71
| 11.298828
| 110
| 22
| 35.59375
| 200
| 3
| 0.799927
| 1.799805
| 136
| 7.469727
| 102
| 45
| 3,925
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 436
| 0
|
85.80194
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 26
| 20,685
| 12,158.5781
| 9,281.91406
| 16.5
|
white
| 21.398438
| 42
| 0.684937
| 0.591919
| 1
| 0
| 1
|
no
| 0.8
| 0.7
|
dnr before sadm
| -1
| 47
| 12.099609
| 144
| 16
| 38.09375
| 100
| 1.799805
| 0.399963
| 1.099854
| 137
| 7.359375
| 91
| 20
| 2,760
| null | 6
|
<2 mo. follow-up
| 6
| 31
| 1
|
73.24298
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 14,628
| 7,396.7266
| 7,355.19922
| 5
|
white
| 20.699219
| 32
| 0.813965
| 0.698975
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr before sadm
| -1
| 57
| null | 120
| 20
| 36.19531
| null | null | null | null | 140
| null | null | null | null | 3
| 2
|
SIP>=30
| 2
| 153
| 1
|
83.20099
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 3
| 12
|
under $11k
| 41
| 8,584
| 4,957.8984
| 4,076.82812
| 10.5
|
white
| 15
| 13
| 0.531982
| 0.208984
| 1
| 1
| 0
|
metastatic
| 0.6
| 0.4
|
no dnr
| 8
| 67
| 9.298828
| 87
| 16
| 36.09375
| null | null | null | 0.699951
| 132
| null | 147
| 14
| null | null | 7
|
<2 mo. follow-up
| 7
| 35
| 1
|
65.34399
|
male
| 1
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 65,291
| null | null | 21
|
white
| 32.59375
| 57
| 0.576904
| 0.46698
| 1
| 1
| 0
|
yes
| 0.5
| 0
|
dnr after sadm
| 24
| 90
| 12.898438
| 100
| 20
| 37.19531
| 290.4375
| null | null | 0.799927
| 139
| 7.449219
| 126
| 17
| null | 0
| 0
|
<2 mo. follow-up
| 0
| 25
| 1
|
70.47998
|
male
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 37
| 124,697
| null | null | 28.75
|
white
| 23
| 56
| 0.599976
| 0.491943
| 2
| 0
| 0
|
yes
| 0.2
| 0.05
|
no dnr
| 33
| 107
| 4.399414
| 70
| 20
| 36.69531
| 304.75
| 2.599609
| 0.299988
| 1
| 143
| 7.449219
| 122
| 14
| 445
| null | null |
Coma or Intub
| 2.585449
| 190
| 1
|
31.17899
|
male
| 1
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 14
|
$25-$50k
| 0
| 120,808
| null | null | 47
|
white
| 34.59375
| 57
| 0.493958
| 0.375977
| 1
| 0
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 12
| 85
| 9.599609
| 60
| 18
| 36.5
| null | 2.399902
| 0.599976
| 0.699951
| 141
| null | 208
| 14
| 3,600
| null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
46.55399
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
$11-$25k
| 0
| 41,692
| 20,516.0469
| 24,885.3906
| 19
|
white
| 15.199219
| 32
| 0.903931
| 0.869995
| 2
| 0
| 0
|
yes
| 0.99
| 0.99
|
no dnr
| 11
| 73
| 6.699219
| 80
| 20
| 36.69531
| 483.3125
| null | null | 1.199951
| 139
| 7.349609
| 97
| 30
| 625
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 429
| 0
|
78.45898
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 3
|
$11-$25k
| 0
| 13,683
| 9,479.7422
| 8,309.50781
| 4
|
white
| 21.097656
| 33
| 0.726929
| 0.642944
| 3
| 0
| 0
|
yes
| 0.8
| 0.75
|
no dnr
| 7
| 111
| 0.099991
| 130
| 16
| 35.59375
| 145
| 2
| 2.699707
| 3
| 130
| 7.259766
| 116
| 67
| 243
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 347
| 1
|
83.59198
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
under $11k
| 0
| 16,860
| 9,524.4922
| 8,219.44531
| 17.5
|
white
| 27.097656
| 29
| 0.672974
| 0.577881
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 10
| 71
| 15.599609
| 64
| 8
| 36.69531
| 160
| 2.699707
| 0.399963
| 1.199951
| 141
| 7.459961
| 156
| 22
| 1,020
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 428
| 0
|
79.75598
|
male
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 17,840
| 12,445.2969
| 11,083.6484
| 16.5
|
white
| 22
| 29
| 0.717896
| 0.631958
| 1
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 1
| 38
| 6.5
| 120
| 15
| 36.69531
| 419
| 3.099609
| null | 1
| 132
| 7.449219
| 92
| 9
| null | 0
| 1
|
adl>=4 (>=5 if sur)
| 1
| 428
| 0
|
78.76794
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 13
| null | 9
| 18,086
| 12,766.6875
| 12,071.7656
| 21.5
|
white
| 18.898438
| 34
| 0.810913
| 0.747925
| 1
| 1
| 1
|
no
| 0.8
| 0.7
|
no dnr
| 8
| 97
| 10.699219
| 70
| 25
| 36.79688
| null | null | null | 2.799805
| 141
| null | 154
| 46
| 1,750
| null | 2
|
adl>=4 (>=5 if sur)
| 2
| 428
| 0
|
28.44099
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 11,832
| 8,365.3359
| 7,131.01953
| 22
| null | 14.099609
| 24
| 0.953979
| 0.93689
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 5
| 49
| 8.398438
| 53
| 36
| 35.79688
| 169.375
| null | null | 1.699951
| 134
| 7.439453
| 57
| 26
| 3,025
| null | null | null | 2.216797
| 426
| 0
|
41.69199
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 15
|
$11-$25k
| 0
| 16,184
| null | null | 16
|
white
| 1.199951
| 20
| 0.925903
| 0.826904
| 1
| 0
| 0
|
metastatic
| 1
| 0.8
|
no dnr
| 4
| 102
| 10.599609
| 70
| 30
| 36.89844
| 121.65625
| null | 7.299805
| 1
| 142
| 7.459961
| 91
| 16
| 3,955
| null | null |
no(M2 and SIP pres)
| 1.597168
| 295
| 1
|
69.76294
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 8,789
| 4,800.1484
| 4,513.07812
| 5
|
white
| 19.699219
| 16
| 0.848999
| 0.751953
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 7
| 80
| 4.199219
| 70
| 20
| 36.09375
| null | 1.699951
| 3.299805
| 1.199951
| 132
| null | 88
| 32
| null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 425
| 0
|
82.14099
|
female
| 0
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 3
| null | null | 9
| 12,928
| 7,280.9922
| 6,365.59766
| 18
|
white
| 30.796875
| 47
| 0.458984
| 0.339966
| 1
| 0
| 1
|
yes
| 0.7
| 0.5
|
dnr after sadm
| 1
| 100
| 13.398438
| 112
| 20
| 36.09375
| null | 2.199707
| null | 0.699951
| 141
| null | 78
| 8
| null | null | null |
<2 mo. follow-up
| 5.588867
| 10
| 1
|
73.28998
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 9
| 22,415
| 14,768.2969
| 13,390.3438
| 21.5
|
white
| 23.699219
| 28
| 0.756958
| 0.679932
| 1
| 0
| 0
|
no
| 0.75
| 0.65
|
no dnr
| 9
| 80
| 12.798828
| 60
| 28
| 36.69531
| 78.32812
| 2
| null | 0.799927
| 148
| 7.439453
| 120
| 30
| 2,125
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 163
| 1
|
70.70197
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 18
|
>$50k
| 0
| 8,339
| 4,873
| 5,015.31641
| 9
|
white
| 15.199219
| 9
| 0.72998
| 0.458984
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.2
|
no dnr
| 6
| 103
| 15.398438
| 121
| 6
| 37.79688
| 520
| 2.5
| 0.799927
| 10.099609
| 147
| 7.339844
| 185
| 67
| 2,870
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 123
| 1
|
50.52399
|
female
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 176,139
| 120,280.312
| 94,567.375
| 29
|
white
| 25.097656
| 58
| 0.797974
| 0.730957
| 7
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 47
| 130
| 19.898438
| 79
| 44
| 37.69531
| 97.95312
| 2.5
| 0.5
| 3.299805
| 148
| 7.449219
| 185
| 56
| 1,160
| null | null | null | 2.606934
| 421
| 0
|
91.68799
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 12
| null | 9
| 9,399
| 5,090.8633
| 5,382.42969
| 7.5
|
black
| 21.699219
| 31
| 0.543945
| 0.345947
| 1
| 0
| 1
|
yes
| 0.7
| 0.2
|
no dnr
| 7
| 77
| 61.296875
| 80
| 30
| 37
| null | null | null | 1
| 143
| null | 435
| 18
| null | null | null |
<2 mo. follow-up
| 7.073242
| 18
| 1
|
54.95398
|
female
| 0
| 14
|
Lung Cancer
|
Cancer
| 2
| 9
|
under $11k
| 0
| 15,766
| 9,523.3125
| 13,740.3359
| 4.333332
|
hispanic
| 22
| 36
| 0.625977
| 0.312988
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.4
|
dnr after sadm
| 1
| 67
| 4.299805
| 112
| 10
| 36.19531
| 330
| 2.599609
| 2.799805
| 1.599854
| 148
| 7.339844
| 100
| 22
| 1,155
| 0
| 2
|
<2 mo. follow-up
| 2
| 58
| 1
|
80.41095
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| null | null | 0
| 10,985
| 5,983.1719
| 5,310.14844
| 8
| null | 14.199219
| 34
| 0.87793
| 0.796997
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 1
| 121
| 11.199219
| 81
| 22
| 36.5
| 244
| 3.299805
| 0.299988
| 3.5
| 135
| 7.449219
| 125
| 37
| 2,775
| null | null | null | 3.723633
| 182
| 1
|
82.90198
|
female
| 1
| 3
|
Coma
|
Coma
| 3
| 12
|
under $11k
| 55
| 12,558
| 7,413.4844
| 6,664.97656
| 30
|
white
| 21
| 56
| 0.252991
| 0.185974
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 123
| 10.599609
| 104
| 24
| 38.59375
| 357.125
| null | null | 1.099854
| 134
| 7.459961
| 79
| 16
| 1,121
| null | null |
<2 mo. follow-up
| 2.826172
| 3
| 1
|
78.80096
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 23,985
| 15,362.7188
| 12,458.1875
| 16.333328
|
white
| 19.398438
| 30
| 0.782959
| 0.712891
| 1
| 1
| 1
|
yes
| 0.95
| 0.9
|
dnr before sadm
| -1
| 60
| 23.898438
| 100
| 16
| 37.89844
| 160
| 4.099609
| 2.5
| 4.599609
| 137
| 7.389648
| 227
| 62
| 202
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 180
| 1
|
94.60095
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 17
|
>$50k
| 9
| 8,027
| 4,217.5195
| 3,730.28906
| 13
|
white
| 24.796875
| 42
| 0.618896
| 0.432983
| 1
| 0
| 1
|
no
| 0.9
| 0.6
|
dnr after sadm
| 1
| 66
| 8.699219
| 116
| 16
| 37.89844
| null | 4.099609
| 1
| 2.799805
| 133
| null | 291
| 39
| 4,525
| null | null |
<2 mo. follow-up
| 6.5625
| 13
| 1
|
47.56998
|
female
| 1
| 28
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 17
|
$25-$50k
| 0
| 141,244
| null | null | 34
|
white
| 25.398438
| 55
| 0.618896
| 0.513916
| 9
| 1
| 0
|
yes
| 0.5
| 0.3
|
no dnr
| 28
| 60
| 21.699219
| 130
| 14
| 38.69531
| 97
| 1.5
| 1.199951
| 0.599976
| 137
| 7.379883
| 313
| 10
| 1,764
| null | 7
|
<2 mo. follow-up
| 7
| 28
| 1
|
55.68799
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 0
| 73,326
| 44,157.9062
| 42,893.875
| 35.666657
|
white
| 12
| 20
| 0.934937
| 0.909912
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 19
| 70
| 6.299805
| 73
| 30
| 35.89844
| 228
| null | 0.599976
| 2.299805
| 136
| 7.299805
| 265
| 116
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 415
| 0
|
76.66296
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 90,617
| 51,941.1562
| 49,604.1562
| 42
|
white
| 28.097656
| 33
| 0.550903
| 0.437988
| 6
| 0
| 0
|
yes
| 0.5
| 0.4
|
no dnr
| 18
| 117
| 8.398438
| 90
| 20
| 36.09375
| null | 3.799805
| 11
| 0.799927
| 136
| null | 89
| 8
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 413
| 0
|
77.87799
|
male
| 0
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 20
| null | 41
| 20,672
| 13,498.3672
| 11,308.9297
| 20.5
|
white
| 27.296875
| 51
| 0.314941
| 0.201996
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.05
|
dnr after sadm
| 2
| 57
| 7.899414
| 100
| 30
| 39.29688
| 121.65625
| 1.899902
| null | 1.799805
| 140
| 7.449219
| 295
| 43
| 5,690
| null | 0
|
<2 mo. follow-up
| 0
| 44
| 1
|
68.98297
|
female
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 9
| 73,746
| 46,496.7812
| 42,932.6562
| 25.5
|
white
| 36.898438
| 74
| 0.470947
| 0.35199
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 33
| 123
| 10.599609
| 102
| 28
| 36.19531
| null | 3.099609
| null | 5.199219
| 148
| null | 155
| 40
| 1,255
| null | 0
|
no(M2 and SIP pres)
| 0
| 410
| 0
|
59.66098
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 22
|
>$50k
| 0
| 4,702
| 2,460.8809
| 2,220.26953
| 14
|
white
| 16.699219
| 21
| 0.878906
| 0.79895
| 1
| 1
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 4
| 123
| 9.898438
| 70
| 20
| 36.09375
| 368.3125
| null | null | 0.799927
| 135
| 7.209961
| 181
| 30
| 1,550
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 410
| 0
|
93.09796
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 9
| 23,038
| 13,553.7969
| 12,280.3359
| 19
|
white
| 35.195313
| 44
| 0.35199
| 0.234985
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 9
| 48
| 10.099609
| 105
| 24
| 37.79688
| 80
| 3.099609
| 0.799927
| 1.199951
| 132
| 7.469727
| 153
| 20
| 1,850
| null | 7
|
<2 mo. follow-up
| 7
| 15
| 1
|
84.79395
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 5,262
| null | null | 8
|
white
| 19.898438
| 21
| 0.795898
| 0.670898
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 5
| 75
| 5.699219
| 96
| 24
| 36.29688
| 244
| 3.599609
| 0.699951
| 0.799927
| 129
| 7.389648
| 139
| 31
| 3,125
| null | null | null | 2.417969
| 408
| 0
|
49.10599
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 58,753
| null | null | 32
|
white
| 31.898438
| 52
| 0.594971
| 0.487
| 13
| 0
| 0
|
yes
| 0.65
| 0.3
|
dnr after sadm
| 7
| 97
| 7
| 78
| 24
| 36.09375
| null | 2.299805
| 2.399902
| 0.699951
| 135
| null | 82
| 15
| 960
| null | null |
<2 mo. follow-up
| 2.718262
| 8
| 1
|
50.92099
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 11
|
under $11k
| 0
| 20,417
| null | null | 16
|
white
| 22.796875
| 37
| 0.838989
| 0.783936
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 73
| 12.298828
| 143
| 30
| 38.29688
| 528.25
| 2.599609
| 1.199951
| 0.799927
| 132
| 7.349609
| 211
| 24
| 627
| null | 2
|
SIP>=30
| 2
| 405
| 0
|
88.82996
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
under $11k
| 0
| 14,288
| 8,781.875
| 7,294.04688
| 15
|
white
| 31.097656
| 36
| 0.545898
| 0.432983
| 1
| 0
| 0
|
no
| 0.65
| 0.5
|
dnr after sadm
| 1
| 107
| 8.298828
| 124
| 24
| 36.29688
| 330
| 1.5
| 0.899902
| 0.799927
| 147
| 7.429688
| 104
| 12
| 4,650
| null | 4
| null | 4
| 60
| 1
|
63.37598
|
female
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 10
| null | 0
| 27,526
| null | null | 14
|
other
| 17.199219
| 31
| 0.895996
| 0.825928
| 1
| 1
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 17
| 55
| 19.199219
| 70
| 28
| 35.59375
| 370.3125
| 3.099609
| 1.199951
| 2.5
| 146
| 7.519531
| 251
| 67
| 1,560
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 400
| 0
|
47.20099
|
male
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 18
|
>$50k
| 0
| 19,269
| 14,394.6953
| 12,077.0781
| 17.5
|
white
| 33.09375
| 41
| 0.505981
| 0.388977
| 1
| 0
| 0
|
yes
| 0.99
| 0.99
|
no dnr
| 8
| 57
| 6.099609
| 70
| 25
| 36.09375
| 533.25
| null | null | 0.699951
| 141
| 7.40918
| 108
| 5
| 2,780
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 399
| 0
|
31.72899
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
>$50k
| 0
| 46,277
| null | null | 20.666656
|
black
| 20.699219
| 26
| 0.917969
| 0.887939
| 1
| 0
| 0
|
no
| 0.95
| 0.85
|
no dnr
| 17
| 130
| 6.899414
| 80
| 20
| 37
| null | null | null | 2.699707
| 144
| null | 79
| 36
| 1,400
| null | null |
no(M2 and SIP pres)
| 1.774414
| 397
| 0
|
51.31299
|
female
| 0
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 18,757
| null | null | 13.5
| null | 19.296875
| 21
| 0.842896
| 0.741943
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 11
| 77
| 11.798828
| 80
| 20
| 35.89844
| null | null | null | 1.699951
| 145
| null | 94
| 16
| 800
| null | null | null | 2.953613
| 397
| 0
|
77.69995
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 13
|
$11-$25k
| 0
| 13,155
| 7,146.6094
| 6,858.62891
| 9.5
|
white
| 18.097656
| 38
| 0.806885
| 0.687988
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 10
| 53
| 4.799805
| 77
| 40
| 35.79688
| 120
| 1.799805
| 0.5
| 1
| 135
| 7.279297
| 115
| 24
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 396
| 0
|
86.07794
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
| null | 0
| 19,059
| null | null | 15
|
white
| 24.796875
| 32
| 0.640991
| 0.459961
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 8
| 79
| 13
| 58
| 44
| 38.09375
| 285.6875
| 2.299805
| 0.5
| 1.199951
| 145
| 7.399414
| 176
| 48
| 1,540
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 395
| 0
|
82.96198
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 5,468
| 3,089.1016
| 2,990.38867
| 11
|
white
| 16.597656
| 25
| 0.845947
| 0.746948
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 5
| 74
| 8.298828
| 72
| 40
| 34.79688
| null | 1.899902
| 3.5
| 0.899902
| 138
| null | 299
| 35
| 1,505
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 393
| 0
|
85.90295
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 8,641
| 5,966.6211
| 4,774.98828
| 18
|
white
| 16.796875
| 35
| 0.836914
| 0.780884
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 6
| 103
| 15.699219
| 58
| 16
| 38.19531
| 436
| 2.699707
| 0.5
| 0.899902
| 144
| 7.459961
| 185
| 20
| 1,510
| null | 7
|
no(M2 and SIP pres)
| 7
| 392
| 0
|
60.85999
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 9
| 8,193
| 4,558.7617
| 4,620.15625
| 5.5
|
white
| 17.5
| 15
| 0.850952
| 0.754883
| 1
| 0
| 0
|
yes
| 0.8
| 0.4
|
no dnr
| 7
| 120
| 5.199219
| 90
| 25
| 36.09375
| 208
| null | null | 1.099854
| 132
| 7.339844
| 537
| 31
| null | 1
| null |
no(M2 and SIP pres)
| 1.166748
| 393
| 0
|
46.71899
|
male
| 0
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 31,701
| 21,135.6094
| 17,827.7969
| 29
|
white
| 22.699219
| 31
| 0.745972
| 0.665894
| 1
| 0
| 0
|
yes
| 0.9
| 0.85
|
no dnr
| 12
| 67
| 15.199219
| 61
| 12
| 38
| 543.25
| 3.099609
| 0.699951
| 1.099854
| 138
| 7.259766
| 111
| 13
| 750
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 391
| 0
|
68.01398
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 9
| null | 0
| 5,924
| 3,249.1504
| 3,604.47852
| 10
|
black
| 16
| 9
| 0.720947
| 0.444946
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.2
|
dnr after sadm
| 4
| 49
| 12.5
| 110
| 14
| 39.29688
| 85
| null | 4.299805
| 0.799927
| 142
| 7.349609
| 86
| 12
| 4,865
| 2
| null | null | 1.838867
| 68
| 1
|
80.05499
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
$25-$50k
| 0
| 75,188
| 36,809.5312
| 36,185.5938
| 48
|
white
| 38
| 54
| 0.381958
| 0.263977
| 2
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 10
| 101
| 14.599609
| 110
| 23
| 38.89844
| 230
| 2.5
| 1.899902
| 1.099854
| 131
| 7.519531
| 123
| 29
| 1,450
| null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
75.33496
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 20
|
$25-$50k
| 0
| 5,624
| 3,108.2344
| 1,921.0791
| 6
|
white
| 13.298828
| 11
| 0.844971
| 0.658936
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 4
| 63
| 7.899414
| 100
| 25
| 38.69531
| 143.3125
| null | 0.799927
| 1.399902
| 143
| 7.419922
| 161
| 33
| 920
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 101
| 1
|
74.15698
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 4
| 12
|
$25-$50k
| 0
| 11,663
| 6,169.6328
| 5,141.63672
| 9.5
|
white
| 20.199219
| 25
| 0.612915
| 0.297974
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.9
|
no dnr
| 8
| 100
| 13.298828
| 120
| 25
| 36.5
| 400
| 3.799805
| null | 1.299805
| 142
| 7.419922
| 184
| 20
| 800
| 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 101
| 1
|
65.52795
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
$11-$25k
| 41
| 30,687
| 20,530.9375
| 16,261.0625
| 11
|
white
| 29.796875
| 24
| 0.536987
| 0.421997
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 1
| 83
| 10.599609
| 80
| 20
| 37.09375
| 253.3125
| null | null | 1
| 147
| 7.379883
| 99
| 25
| null | 2
| 1
|
no(M2 and SIP pres)
| 1
| 388
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.